The evolution of precision medicine has transformed the life science industry. The identification of biomarkers and genes associated with diseases has not only led to earlier disease detection, but also the ability to identify the best treatment for individuals with certain kinds of cancers and other chronic and rare conditions.

The rise of artificial intelligence applications for life science companies, particularly in the research and development space, is transforming the industry as earlier medical interventions and more sophisticated diagnostics and therapeutics improve patient outcomes and extend the human lifespan.

Jim Craig, Senior Vice President – Underwriting at Munich Re Specialty – North America , has worked in the life science liability underwriting space for over 25 year

See Full Page